Folate Metabolism–Based Risk Stratification Identifies CYP27B1 as a Determinant of Tumor Progression in HNSCC - Top-Institutions - MDSpire

Folate Metabolism–Based Risk Stratification Identifies CYP27B1 as a Determinant of Tumor Progression in HNSCC

  • By

  • Kai, Zhang

  • Hu, Haixia

  • Liu, Bingya

  • April 21, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Oncology

  • #2

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Oncology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

  • #4

    North Central Cancer Treatment Group (NCCTG)
    North Central Cancer Treatment Group (NCCTG)

    Rochester, MN

    Key Differentiators

    • Oncology

  • #5

    National Surgical Adjuvant Breast and Bowel Project (NSABP)
    National Surgical Adjuvant Breast and Bowel Project (NSABP)

    Pittsburgh, PA

    Key Differentiators

    • Oncology

Original Source(s)

Folate Metabolism–Based Risk Stratification Identifies CYP27B1 as a Determinant of Tumor Progression in HNSCC

  • by Kai, Zhang , Hu, Haixia , Liu, Bingya

  • April 21, 2026

Related Content

Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma

Management of toxicities from antibody – drug conjugates in breast cancer

Immune biomarker landscape and fusion partner–phenotype associations in thoracic and head-and-neck NUT carcinoma